Comparative effectiveness, safety, and costs of rivaroxaban and warfarin among morbidly obese patients with atrial fibrillation - Peterson, Eric D.; Ashton, Veronica; Chen, Yen-Wen; Wu, Bingcao; Spyropoulos, Alex C. (The American heart journal, 2019)
Keywords: Anticoagulants; Anticoagulants - economics; Anticoagulants - therapeutic use; Atrial Fibrillation - complications; Atrial Fibrillation - drug therapy; Atrial Fibrillation - epidemiology; Bleeding; Body mass; Body mass index; Body size; Body weight; Cardiac arrhythmia; Codes; Committees; Comorbidity; Confidence intervals; Costs; Diabetes; Diagnostic systems; Drug Costs; Embolism; Embolisms; Factor Xa Inhibitors - economics; Female; Fibrillation; Follow-Up Studies; Health care; Health risks; Heart failure; Heart transplantation; Heart valves; Humans; Hypertension; Identification methods; Incidence; Ischemia; Male; Medicare; Middle Aged; Morbidity - trends; Obesity; Obesity, Morbid - complications; Obesity, Morbid - epidemiology; Patients; Pharmacy; Population; Prescription drugs; Resource utilization; Retrospective Studies; Rivaroxaban - economics; Rivaroxaban - therapeutic use; Statistical analysis; Statistical models; Stenosis; Stroke; Stroke - epidemiology; Stroke - etiology; Stroke - prevention & control; Survival Rate - trends; United States - epidemiology; Warfarin; Warfarin - economics; Warfarin - therapeutic use; United States